UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
A Step Closer to Making Precision Resynchronization Therapy a Reality for All Patients: Corify at Clinical Guidelines 

💡 A Step Closer to Making Precision Resynchronization Therapy a Reality for All Patients: Corify at Clinical Guidelines We are proud to...

Read More »
Corify Care announces AI collaboration with Mayo Clinic to improve cardiac arrhythmia care

[Valencia, 28/05/2025] – Corify Care, an AI-driven medical technology company specializing in global cardiac mapping and real-time precision guidance for the treatment...

Read More »
Corify Care at HRS: 10 Scientific Contributions Shaping the future of Non-Invasive Cardiac Mapping

[Valencia, 28/05/2025] Corify Care, an AI-driven medical technology company specializing in global cardiac mapping and real-time precision guidance for the treatment of...

Read More »